FGF receptors ubiquitylation: dependence on tyrosine kinase activity and role in downregulation

No abstract is available for this paper.

• Publication year

  2002

• Venue

  FEBS Letters

• Publication date

  2002-09-25

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0014-5793(02)03255-6PMID 12297284
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• FRS2α attenuates FGF receptor signaling by Grb2- mediated recruitment of the ubiquitin ligase Cbl

  2002cited by this paper
• Differential Activation of Cysteine‐Substitution Mutants of Fibroblast Growth Factor Receptor 3 Is Determined by Cysteine Localization

  2002cited by this paper
• Ubiquitin and proteasomes: Protein regulation by monoubiquitin

  2001cited by this paper
• Do VHL and HIF-1 mirror p53 and Mdm-2? Degradation-transactivation loops of oncoproteins and tumor suppressors

  2001cited by this paper
• Cbl: many adaptations to regulate protein tyrosine kinases

  2001cited by this paper
• Distinct missense mutations of the FGFR3 lys650 codon modulate receptor kinase activation and the severity of the skeletal dysplasia phenotype.

  2000cited by this paper
• c-Cbl Is a Suppressor of the Neu Oncogene*

  2000cited by this paper
• The ubiquitin system

  2000cited by this paper
• The Transmembrane Mutation G380R in Fibroblast Growth Factor Receptor 3 Uncouples Ligand-Mediated Receptor Activation from Down-Regulation

  2000cited by this paper
• Structure of a c-Cbl-UbcH7 complex: RING domain function in ubiquitin-protein ligases.

  2000cited by this paper
• Ubiquitination and Endocytosis of Plasma Membrane Proteins: Role of Nedd4/Rsp5p Family of Ubiquitin-Protein Ligases

  2000cited by this paper
• FGFs, heparan sulfate and FGFRs: complex interactions essential for development.

  2000cited by this paper
• Signal transduction by fibroblast growth factor receptors.

  1999cited by this paper
• Fibroblast growth factor receptors (FGFRs) and their roles in limb development

  1999cited by this paper
• The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase.

  1999cited by this paper
• ER protein quality control and proteasome-mediated protein degradation.

  1999cited by this paper
• The Cbl protooncoprotein stimulates CSF‐1 receptor multiubiquitination and endocytosis, and attenuates macrophage proliferation

  1999cited by this paper
• Skeletal Dysplasia and Defective Chondrocyte Differentiation by Targeted Overexpression of Fibroblast Growth Factor 9 in Transgenic Mice

  1999cited by this paper
• The ubiquitin-proteasome system and endocytosis.

  1999cited by this paper
• Gettin' down with ubiquitin: turning off cell-surface receptors, transporters and channels.

  1999cited by this paper
• The ubiquitin system.

  1998cited by this paper
• The ErbB-2/HER2 oncogenic receptor of adenocarcinomas: from orphanhood to multiple stromal ligands.

  1998cited by this paper
• Constitutive activation of fibroblast growth factor receptor 3 by mutations responsible for the lethal skeletal dysplasia thanatophoric dysplasia type I.

  1998cited by this paper
• c-Cbl/Sli-1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptor.

  1998cited by this paper
• Ubiquitin and the control of protein fate in the secretory and endocytic pathways.

  1998cited by this paper
• Novel Recognition Motif on Fibroblast Growth Factor Receptor Mediates Direct Association and Activation of SNT Adapter Proteins*

  1998cited by this paper
• Ubiquitin‐dependent internalization and down‐regulation of plasma membrane proteins

  1997cited by this paper
• Structures of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitors.

  1997cited by this paper
• Degradation of the Met tyrosine kinase receptor by the ubiquitin-proteasome pathway

  1997cited by this paper
• FGFR activation in skeletal disorders: too much of a good thing.

  1997cited by this paper
• Epidermal Growth Factor Induces Ubiquitination of Eps15*

  1997cited by this paper
• Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia

  1996cited by this paper
• Ubiquitination of a yeast plasma membrane receptor signals its ligand-stimulated endocytosis.

  1996cited by this paper
• The ubiquitin conjugation system is required for ligand‐induced endocytosis and degradation of the growth hormone receptor.

  1996cited by this paper
• Fibroblast-growth-factor receptor mutations in human skeletal disorders.

  1995cited by this paper
• The epidermal growth factor receptor is covalently linked to ubiquitin.

  1995cited by this paper
• Ligand-induced polyubiquitination of receptor tyrosine kinases.

  1995cited by this paper
• Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3

  1995cited by this paper
• [Ligand-induced polyubiquitination of receptor tyrosine kinases].

  1995cited by this paper
• A common FGFR3 gene mutation in hypochondroplasia.

  1995cited by this paper
• Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia.

  1994cited by this paper
• A tyrosine residue in the juxtamembrane segment of the platelet-derived growth factor beta-receptor is critical for ligand-mediated endocytosis.

  1994cited by this paper
• Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia

  1994cited by this paper
• Complexity of FGF receptors: genetic basis for structural diversity and functional specificity

  1992cited by this paper
• The FGF family of growth factors and oncogenes.

  1992cited by this paper
• Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor.

  1991cited by this paper
• Continuously growing bipotential and monopotential myogenic, adipogenic, and chondrogenic subclones isolated from the multipotential RCJ 3.1 clonal cell line.

  1990cited by this paper
• Ubiquitinated protein conjugates are specifically enriched in the lysosomal system of fibroblasts

  1990cited by this paper

• Breast Cancer Progression by the FGF/FGFR Axis: A Metabolic Perspective

  2025cites this paper
• Concurrence of FGFR1 mutations modulates oncogenesis in glioneuronal tumors

  2025cites this paper
• Negative regulation of receptor tyrosine kinases by ubiquitination: Key roles of the Cbl family of E3 ubiquitin ligases

  2022cites this paper
• Regenerative responses of rabbit corneal endothelial cells to stimulation by fibroblast growth factor 1 (FGF1) derivatives, TTHX1001 and TTHX1114

  2021cites this paper
• Negative Regulation of FGFR (Fibroblast Growth Factor Receptor) Signaling

  2021cites this paper
• Mutant FGFR3 associated with SADDAN disease causes cytoskeleton disorganization through PLCγ1/Src-mediated paxillin hyperphosphorylation.

  2018cites this paper
• Current Care and Investigational Therapies in Achondroplasia

  2017cites this paper
• Statins do not inhibit the FGFR signaling in chondrocytes.

  2017cites this paper
• Molecular therapeutic strategies for FGFR3 gene-related skeletal dysplasia

  2017cites this paper
• Role of RAB25 and RAB11 GTPases in bladder tumorigenesis

  2016cites this paper
• The impact of polyphenols on chondrocyte growth and survival: a preliminary report

  2015cites this paper
• Mitotic Membrane Turnover Coordinates Differential Induction of the Heart Progenitor Lineage.

  2015cites this paper
• Endocytosis of Fgf8 Is a Double-Stage Process and Regulates Spreading and Signaling

  2014cites this paper
• Role of dimerization efficiency of transmembrane domains in activation of fibroblast growth factor receptor 3.

  2013cites this paper
• Molecular Genetics of Achondroplasia

  2013cites this paper
• Postnatal Soluble FGFR3 Therapy Rescues Achondroplasia Symptoms and Restores Bone Growth in Mice

  2013cites this paper
• and -independent pathways for hematopoietic transformation -dependent γ Constitutively activated FGFR3 mutants signal through PLC

  2013cites this paper
• Oncogenic role of fibroblast growth factor receptor 3 in tumorigenesis of urinary bladder cancer.

  2013cites this paper
• Recent Patents on Achondroplasia: Latest Research Development

  2013cites this paper
• Cbl‐family proteins as regulators of cytoskeleton‐dependent phenomena

  2013cites this paper
• Sixteen years and counting: The current understanding of fibroblast growth factor receptor 3 (FGFR3) signaling in skeletal dysplasias

  2012cites this paper
• A novel tyrosine kinase inhibitor restores chondrocyte differentiation and promotes bone growth in a gain-of-function Fgfr3 mouse model.

  2012cites this paper
• Effect of the G375C and G346E Achondroplasia Mutations on FGFR3 Activation

  2012cites this paper
• Ligand activation leads to regulated intramembrane proteolysis of fibroblast growth factor receptor 3

  2011cites this paper
• The physical basis of FGFR3 response to fgf1 and fgf2.

  2011cites this paper
• Defining the role of HSP90 in the stability of FGFR3 and as a drug target for the treatment of skeletal diseases and cancer

  2011cites this paper
• Effects of diadenosine tetraphosphate on FGF9-induced chloride flux changes in achondroplastic chondrocytes

  2011cites this paper
• Fibroblast Growth Factor Receptor 3 (FGFR3) Is a Strong Heat Shock Protein 90 (Hsp90) Client

  2011cites this paper
• The A391E mutation enhances FGFR3 activation in the absence of ligand.

  2011cites this paper
• Predictive Computational Models of Mitogen-activated Protein Kinase Signaling Networks Driven by Quantitative Measurements of System Dynamics.

  2010cites this paper
• Physical Basis behind Achondroplasia, the Most Common Form of Human Dwarfism*

  2010cites this paper
• SPECIAL FOCUS: THE ROLE OF TRANSMEMBRANE DOMAINS IN ADHESION

  2010cites this paper
• Bortezomib therapeutic effect is associated with expression and mutation of FGFR3 in human lymphoma cells.

  2010cites this paper
• Bortezomib Therapeutic Effect Is Associated with Expression

  2010cites this paper
• Mutant Fibroblast Growth Factor Receptor 3 Induces Intracellular Signaling and Cellular Transformation in a Cell Type- and Mutation-Specific Manner

  2009influential citation
• Fibroblast growth factor signaling in development of the cerebral cortex

  2009influential citation
• Signaling mechanisms and developmental function of fibroblast growth factor receptors in zebrafish

  2009cites this paper
• FGF-1: from biology through engineering to potential medical applications.

  2008cites this paper
• Sprouty 2 disturbs FGFR3 degradation in thanatophoric dysplasia type II: a severe form of human achondroplasia.

  2008cites this paper
• FGF-1: From Biology Through Engineering to Potential Medical Applications

  2008cites this paper
• Ubiquitination of fibroblast growth factor receptor 1 is required for its intracellular sorting but not for its endocytosis.

  2008cites this paper
• Critical Reviews in Clinical Laboratory Sciences

  2008cites this paper
• The control of transmembrane helix transverse position in membranes by hydrophilic residues.

  2007cites this paper
• The localization of FGFR3 mutations causing thanatophoric dysplasia type I differentially affects phosphorylation, processing and ubiquitylation of the receptor

  2007cites this paper
• Bisindolylmaleimide I Suppresses Fibroblast Growth Factor-mediated Activation of Erk MAP Kinase in Chondrocytes by Preventing Shp2 Association with the Frs2 and Gab1 Adaptor Proteins*

  2007cites this paper
• Effect of diadenosine polyphosphates in achondroplasic chondrocytes: inhibitory effect of Ap4A on FGF9 induced MAPK cascade.

  2007cites this paper
• Sequence to topography relationship in membrane-inserted hydrophobic helices

  2007influential citation
• Activation of the Fibroblast Growth Factor Receptor 3 in Bladder Cancer

  2007cites this paper
• Proteolytic and lipolytic responses to starvation.

  2006cites this paper
• K644E/M FGFR3 mutants activate Erk1/2 from the endoplasmic reticulum through FRS2 alpha and PLC gamma-independent pathways.

  2006cites this paper
• K644E/M FGFR3 Mutants Activate Erk1/2 from the Endoplasmic Reticulum through FRS2α and PLCγ-independent Pathways

  2006cites this paper
• Neutron diffraction studies of fluid bilayers with transmembrane proteins: structural consequences of the achondroplasia mutation.

  2006cites this paper
• Ubiquitin Ligase Cbl‐b Downregulates Bone Formation Through Suppression of IGF‐I Signaling in Osteoblasts During Denervation

  2006cites this paper
• FGFR3 dimer stabilization due to a single amino acid pathogenic mutation.

  2006cites this paper
• The achondroplasia mutation does not alter the dimerization energetics of the fibroblast growth factor receptor 3 transmembrane domain.

  2006cites this paper
• Suppressors of cytokine signaling (SOCS) 1 and SOCS3 interact with and modulate fibroblast growth factor receptor signaling

  2006influential citation
• A role of the protein Cbl in FGF-2-induced angiogenesis in murine brain endothelial cells.

  2005cites this paper
• Cell responses to FGFR3 signalling: growth, differentiation and apoptosis.

  2005cites this paper
• Constitutively activated FGFR3 mutants signal through PLCγ- dependent and-independent pathways for hematopoietic transformation. Running title: Systematic mutational analysis of autophosphorylated tyrosine residues

  2005cites this paper
• The kinetics of FGF-2 binding to heparan sulfate proteoglycans and MAP kinase signaling.

  2005cites this paper
• Different intracellular trafficking of FGF1 endocytosed by the four homologous FGF receptors

  2005cites this paper
• Constitutively activated FGFR3 mutants signal through PLCgamma-dependent and -independent pathways for hematopoietic transformation.

  2004cites this paper
• Defective lysosomal targeting of activated fibroblast growth factor receptor 3 in achondroplasia.

  2004cites this paper
• Signaling, internalization, and intracellular activity of fibroblast growth factor.

  2004cites this paper
• Cbl-mediated Degradation of Lyn and Fyn Induced by Constitutive Fibroblast Growth Factor Receptor-2 Activation Supports Osteoblast Differentiation*

  2004cites this paper
• Intracellular trafficking of FGF1 endocytosed by its four tyrosine kinase receptors

  2004cites this paper
• Thromboxane A2 Receptor Agonists Antagonize the Proangiogenic Effects of Fibroblast Growth Factor-2: Role of Receptor Internalization, Thrombospondin-1, and &agr;v&bgr;3

  2004cites this paper
• Tyrosine Residues Direct the Ubiquitination and Degradation of the NY-1 Hantavirus G1 Cytoplasmic Tail

  2003cites this paper
• Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 1270 Roles of the Shb and Cbl Proteins in Signal Transduction and Blood Vessel Formation

  2003cites this paper
• Fibroblast growth factor receptor-3 as a therapeutic target for Achondroplasia--genetic short limbed dwarfism.

  2003cites this paper
• Cbl signaling networks in the regulation of cell function

  2003cites this paper